102 related articles for article (PubMed ID: 2948063)
1. Effect of human atrial natriuretic peptide on angiotensin II-induced secretion of aldosterone in man.
Vierhapper H
Klin Wochenschr; 1986; 64 Suppl 6():50-2. PubMed ID: 2948063
[TBL] [Abstract][Full Text] [Related]
2. Prolonged administration of human atrial natriuretic peptide in healthy men. Reduced aldosteronotropic effect of angiotensin II.
Vierhapper H; Nowotny P; Waldhäusl W
Hypertension; 1986 Nov; 8(11):1040-3. PubMed ID: 2945783
[TBL] [Abstract][Full Text] [Related]
3. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
4. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II.
Cargill RI; Struthers AD; Lipworth BJ
Cardiovasc Res; 1995 Jan; 29(1):108-11. PubMed ID: 7895227
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Klemm SA; Tunny TJ; Gordon RD
J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
[TBL] [Abstract][Full Text] [Related]
6. Effects of synthetic atrial natriuretic factor (ANF) on renin-aldosterone axis in the conscious newborn calf.
Amadieu M; Giry J; Barlet JP
J Dev Physiol; 1989 Jan; 11(1):15-8. PubMed ID: 2529306
[TBL] [Abstract][Full Text] [Related]
7. Effects of human atrial natriuretic peptide on the pressor action of noradrenaline and angiotensin II in normal subjects.
Uehlinger DE; Weidmann P; Gnädinger MP; Shaw S
J Hypertens Suppl; 1985 Dec; 3(3):S319-21. PubMed ID: 2856727
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
9. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis.
Waldhäusl W; Vierhapper H; Nowotny P
J Clin Endocrinol Metab; 1986 May; 62(5):956-9. PubMed ID: 2937802
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.
Cargill RI; Struthers AD; Lipworth BJ
Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006
[TBL] [Abstract][Full Text] [Related]
11. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
12. Permissive action of glucocorticoid substitution therapy on the effects of atrial natriuretic peptide (hANP) in patients with adrenocortical insufficiency.
Damjancic P; Vierhapper H
Exp Clin Endocrinol; 1990 Aug; 95(3):315-21. PubMed ID: 2174002
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man.
Anderson JV; Struthers AD; Payne NN; Slater JD; Bloom SR
Clin Sci (Lond); 1986 May; 70(5):507-12. PubMed ID: 2938872
[TBL] [Abstract][Full Text] [Related]
14. Human alpha atrial natriuretic peptide inhibits angiotensin stimulated aldosterone biosynthesis in bovine adrenal glands.
Frisina N; Buemi M; Lasco A; Macri I; Squadrito F
Horm Metab Res; 1987 Jul; 19(7):309-11. PubMed ID: 2957298
[TBL] [Abstract][Full Text] [Related]
15. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
16. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.
Volpe M; Odell G; Kleinert HD; Camargot MJ; Laragh JH; Lewicki JA; Maack T; Vaughan ED; Atlas SA
J Hypertens Suppl; 1984 Dec; 2(3):S313-5. PubMed ID: 6242558
[TBL] [Abstract][Full Text] [Related]
18. Renin-aldosterone axis in ethanol intoxication: effect of A II infusion.
Nieminen MM; Linkola J; Fyhrquist F; Tikkanen I; Forslund T
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):137-40. PubMed ID: 2987138
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
Schafferhans K; Heidbreder E; Hummel S; Heidland A
Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
